Zydus Wellness Q2 FY27 Earnings Call: Net Sales Jump 75% On Acquisition, Comfort Click Slows To 12% (ZYDUSWELL)

Zydus Wellness Ltd held its Q2 FY27 earnings call on November 03, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Acquisition-boosted top line; like-to-like momentum intact

• Q2 FY 2026-2027 consolidated net sales of Rs.11,227 million, +74.6% YoY — H1 FY 2026-2027 net sales at Rs.25,526 million, +70.1% YoY, boosted by the Comfort Click acquisition and core momentum.
• Q2 FY 2026-2027 EBITDA of Rs.855 million, +271.7% YoY — H1 FY 2026-2027 EBITDA grew 83.2% to Rs.3,272 million, with like-to-like EBITDA margin expansion across businesses and gross margin expansion in the core business accelerated by the higher-margin Comfort Click business.
• Domestic portfolio grew 29.2% YoY in Q2 FY 2026-2027 — seasonal brands +123.5% (off a low base), skin & hair care +37.5%, food & nutrition +25.1%.
• International business posted like-to-like growth of 12.4% in Q2 FY 2026-2027 — 18.6% in H1 FY 2026-2027.
• Demand backdrop: high commodity-driven inflation — but sustained consumption momentum with improving rural offline markets; e-commerce and quick commerce continued to increase their contribution to overall sales.
• Key launches in Q2 FY 2026-2027 — Sugar Free monk fruit sweetener (non-erythritol), Right Bite Max Protein Crunchy Cookies with 10g protein (no palm oil, maida, or added sugar), and Comfort Click additions (vitamin B complex, omega-3 triglycerides, vitamin D3+K2 under the Weight World brand).

Everyuth, Complan and Nutralite outperforming; Ever Youth climbs to #4

• Ever Youth rank climbed to #4 in FY 2026-2027 — from #7 a few years ago and #5 previously, in a facial cleansing category (face wash, scrubs, three mask types) that CEO Tarun Arora sized at ~Rs.4,500 crore; growth is broad-based and management called it a validation of category-building, premiumization and innovation strategy, explicitly not a one-year windfall.
• Complan grew double-digit in Q2 FY 2026-2027, outpacing the category — three consecutive quarters of positive momentum through Q2 FY 2026-2027 despite a generally pressured category; relaunch with 50% less sugar, Complan NutriGrow (2-6 year toddler segment) relaunched in Q1 FY 2026-2027, and campaigns with celebrity Vaibhav Suryavanshi drew a very good consumer response.
• Everyuth delivered double-digit growth led by tan removal and peel-off franchises — with significant facial cleansing market share gains; skin & hair care delivered 35%+ growth in Q2/H1 FY 2026-2027, which management attributes to consistent high double-digit growth over the last 5-7 years.
• Nutralite posted strong double-digit growth despite commodity headwinds — Sugar Free sustained double-digit growth; Cuticolor saw strong uptake in organized channels and launched Bright Brown in the safer hair color segment.
• Right Bite has more than doubled its historical growth rates — and exceeded those estimates in Q2 FY 2026-2027; management is sustaining growth without discounting, via targeted omnichannel brand building and rapid product iteration, despite new entrants and larger players investing heavily in the category.
• Rural demand remains robust — rural growth rates slightly higher than urban, with Glucon-D, Nycil and Complan sugar-free holding well, though the company's rural portfolio is significantly smaller than larger FMCG peers'.

Growth moderated to 12% in Q2; management holds double-digit view

• Comfort Click growth moderated from 25% in Q1 FY 2026-2027 to 12% in Q2 FY 2026-2027 — management attributed the slowdown to a small shift in some prime days between June and July and lost momentum in one market during the old-to-new website transition; Q2 came in slightly below expectation.
• H1 FY 2026-2027 Comfort Click (PCL) growth of 18% — in line with expectations; management remains consistent in its view of double-digit growth for the business, citing consistency on a moving-average basis, and will "wait and watch."
• One or two markets have seen an Amazon slowdown — CEO Tarun Arora framed it as temporary and "not a systemic number"; Comfort Click has listed on additional marketplaces such as Boots and a couple of others, providing cover and growth opportunity.
• Management reiterated its estimate of an 11 billion+ VMS market — across its addressable European markets (estimate shared at acquisition), and remains steadfast that the business will keep shifting online.
• Competitive intensity in core markets higher than imagined one year after the acquisition — management framed it as expected when performing well, with some cyclicity ("highs and lows") across markets, "not a big surprise."
• Analyst Nandan Vartak (Wealth Managers) challenged the Comfort Click margin math — citing a ~Rs.500 crore quarterly run rate (analyst estimate referencing FY 2025-2026), an 18-20% growth profile for FY 2025-2026, and a 14-15% EBITDA margin per management's prior indication; he argued the math implies Comfort Click margins were likely in low single digits in Q2 FY 2026-2027. CEO Tarun Arora rejected the like-to-like margin-pressure inference, saying margins are "holding rather well" and "consistent"; no segment-level numbers were disclosed.

Gross margin defended like-for-like; calibrated pricing continues

• Like-for-like, Q2 FY 2026-2027 gross margins are better than Q2 FY 2025-2026 despite inflation — responding to analyst Ajay Thakur's flag that consolidated gross margin tracked slightly below the ~65% level sustained through Q1 FY 2026-2027; management attributed the sequential dip to seasonally elevated Glucon-D and Nycil mix in Q4 FY 2025-2026 and Q1 FY 2026-2027.
• Blended price increase taken so far in FY 2026-2027 is less than 2% (approximately) — only on specific products/SKUs with direct input-cost inflation impact; further calibrated, selective increases are planned over H2 FY 2026-2027 depending on commodity movement.
• Commodity inflation expected to remain in single digits for FY 2026-2027 — aided by annual tie-ups on inputs like dextrose; palm oil has stabilized, while rises in milk, PD, or plastics would trigger responses.
• A&P steady state: domestic ~12.5-13% of sales, Comfort Click ~23-24% — domestic A&P to remain consistent at ~12-13% of sales in the short-to-medium term (no specific FY provided), with opportunistic trims of ~0.5% possible; management will improve EBITDA margins via gross-margin enhancement and operating leverage rather than cutting marketing.
• Management is "quite confident" of moving EBITDA margins as desired over the medium term (period unspecified) — in line with the previously communicated mid-to-high teen EBITDA margin aspiration (mid-to-long term; period unspecified), driven by gross margin gains plus operating leverage as the business scales.
• Domestic reinvestment weighed on the bottom line in Q2 FY 2026-2027 — the domestic business grew with improved gross margins, but reinvestment including brand building impacted the overall bottom line.

Summer disruption absorbed; new launches still a small growth slice

• Seasonal brands (Glucon-D, Nycil) grew almost 120% in Q2 FY 2026-2027 but are down 8.7% in H1 FY 2026-2027 — management attributed the negative H1 to Q1 FY 2026-2027 being significantly impacted by summer; FY 2026-2027 is the first year summer brands struggled in Q1. Management had no ready FY25 number for comparison against the normal summer year the analyst cited.
• Domestic business delivered 13%+ growth in H1 FY 2026-2027 — in line with management's long-stated double-digit domestic growth objective; management believes the business is becoming immune to seasonality, though cyclical summer-brand ups and downs will persist.
• Products launched over the last 3-4 years contribute closer to 4% of growth in FY 2026-2027 — products launched in the last one year contribute about 2%; management noted strong sustenance of new launches at a differential level.
• Management declined to disclose the summer portfolio's contribution to Q2 FY 2026-2027 domestic business — reiterating it only shares segment growth rates, not contribution splits; it also declined to comment on whether the marketplace slowdown persisted into October (Q3 FY 2026-2027), stating it does not share next-quarter numbers.

Qualitative outlook only; margin intent hedged against volatility

• No numeric guidance was given — management remains focused on innovation, digital transformation, and disciplined growth, and expects sustained, sustainable growth with further margin expansion (qualitative outlook, Q2 FY 2026-2027 call).
• H2 FY 2026-2027 gross margin outlook: management believes it can hold gross margin levels — despite a very strong H2 FY 2025-2026 base ("high base effect") and current inflationary pressures; delivery depends on tight cost management and price increases wherever required. CEO Tarun Arora cautioned the volatile environment makes outcomes hard to predict and committed only to intent and actions, not guaranteed outcomes.
• Comfort Click expected to stay on course for double-digit growth in H2 FY 2026-2027 — after 18% growth in H1 FY 2026-2027; on a hypothetical return to 20% growth, the CEO declined to commit to consolidated gross margin reverting to the 65% range in non-seasonal quarters, saying margins would remain "in a similar zone" and he would revert with product-mix detail.
• Comfort Click EBITDA margin expectation of 14-15% reiterated as the planned steady state (period unspecified) — the company does not disclose individual brand or business-wise margins.
• Key risk flagged: continued inflation could dent consumer confidence and reduce consumption — management is more worried about this than about margin execution, though the current consumption environment looks good and actions are in place to keep moving margins up.
• Next results update: Q3 FY 2026-2027 — management indicated it will reconvene with analysts next quarter; no additional figures or outlook were provided in the closing segment.